Long-term Effects of Therapy with Ranibizumab on Diabetic Retinopathy Severity and Baseline Risk Factors for Worsening Retinopathy

Purpose To assess the effects of intravitreal ranibizumab on diabetic retinopathy (DR) severity when administered for up to 3 years, evaluate the effect of delayed initiation of ranibizumab therapy on DR severity, and identify baseline patient characteristics associated with the development of proli...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Minn.), 2015-02, Vol.122 (2), p.367-374
Hauptverfasser:	Ip, Michael S., MD, Domalpally, Amitha, MD, Sun, Jennifer K., MD, MPH, Ehrlich, Jason S., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Angiogenesis Inhibitors - adverse effects Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Cross-Over Studies Diabetic Retinopathy - diagnosis Diabetic Retinopathy - drug therapy Disease Progression Double-Blind Method Female Follow-Up Studies Humans Intravitreal Injections Macular Edema - diagnosis Macular Edema - drug therapy Male Middle Aged Ophthalmology Ranibizumab Retinal Neovascularization - diagnosis Risk Factors Severity of Illness Index Tomography, Optical Coherence Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!